DISC MEDICINE INC(NASDAQ:IRON) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to IRON. IRON was compared to 563 industry peers in the Biotechnology industry. IRON scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IRON is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

IRON had negative earnings in the past year.

In the past year IRON has reported a negative cash flow from operations.

IRON had negative earnings in each of the past 5 years.

IRON had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -22.01%, IRON is in the better half of the industry, outperforming 77.26% of the companies in the same industry.

Looking at the Return On Equity, with a value of -24.65%, IRON belongs to the top of the industry, outperforming 82.77% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-22.01%
ROE	-24.65%
ROIC	N/A

ROA(3y)-22.05%

ROA(5y)-23.6%

ROE(3y)-24.43%

ROE(5y)-26.32%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IRON does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IRON has more shares outstanding than it did 1 year ago.

Compared to 1 year ago, IRON has a worse debt to assets ratio.

2.2 Solvency

IRON has an Altman-Z score of 18.78. This indicates that IRON is financially healthy and has little risk of bankruptcy at the moment.

IRON has a better Altman-Z score (18.78) than 94.14% of its industry peers.

A Debt/Equity ratio of 0.06 indicates that IRON is not too dependend on debt financing.

With a Debt to Equity ratio value of 0.06, IRON is not doing good in the industry: 63.41% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Altman-Z	18.78

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

IRON has a Current Ratio of 21.17. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.

IRON has a Current ratio of 21.17. This is amongst the best in the industry. IRON outperforms 95.74% of its industry peers.

A Quick Ratio of 21.17 indicates that IRON has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 21.17, IRON belongs to the top of the industry, outperforming 95.74% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	21.17
Quick Ratio	21.17

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IRON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.67%.

EPS 1Y (TTM)-16.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-8.89%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 18.82% on average over the next years. This is quite good.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-25.52%

EPS Next 2Y-12.26%

EPS Next 3Y-2.08%

EPS Next 5Y18.82%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IRON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IRON. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

IRON's earnings are expected to decrease with -2.08% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-12.26%

EPS Next 3Y-2.08%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

IRON does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DISC MEDICINE INC

NASDAQ:IRON (5/5/2025, 8:19:14 PM)

After market: 48.6 0 (0%)

48.6

-0.91 (-1.84%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)02-27 2025-02-27/bmo

Earnings (Next)05-19 2025-05-19/bmo

Inst Owners67.45%

Inst Owner Change0.54%

Ins Owners1.13%

Ins Owner Change3.54%

Market Cap1.68B

Analysts84.71

Price Target100.37 (106.52%)

Short Float %10.14%

Short Ratio6.16

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)14.96%

Min EPS beat(2)12.77%

Max EPS beat(2)17.14%

EPS beat(4)3

Avg EPS beat(4)8.03%

Min EPS beat(4)-6.92%

Max EPS beat(4)17.14%

EPS beat(8)5

Avg EPS beat(8)-1.23%

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)3.78%

PT rev (3m)3.78%

EPS NQ rev (1m)2.47%

EPS NQ rev (3m)-1.95%

EPS NY rev (1m)0.57%

EPS NY rev (3m)3.24%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	3.79
P/tB	3.79
EV/EBITDA	N/A

EPS(TTM)-3.99

EYN/A

EPS(NY)-5.01

Fwd EYN/A

FCF(TTM)-2.73

FCFYN/A

OCF(TTM)-2.71

OCFYN/A

SpS0

BVpS12.81

TBVpS12.81

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-22.01%
ROE	-24.65%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-22.05%

ROA(5y)-23.6%

ROE(3y)-24.43%

ROE(5y)-26.32%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	323.72%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	21.17
Quick Ratio	21.17
Altman-Z	18.78

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)193.13%

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-16.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-8.89%

EPS Next Y-25.52%

EPS Next 2Y-12.26%

EPS Next 3Y-2.08%

EPS Next 5Y18.82%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-42.34%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-57.44%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-28.39%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-27.86%

OCF growth 3YN/A

OCF growth 5YN/A

DISC MEDICINE INC (IRON) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens